Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

Por Goyal, G, Bartley, A C, Patnaik, M M, Litzow, M R, Al-Kali, A, Go, R S
Publicado no Blood Cancer J (2017)

IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes

Por Pardanani, A, Finke, C, Lasho, T L, Al-Kali, A, Begna, K H, Hanson, C A, Tefferi, A
Publicado em 2012

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

Por Kenderian, S S, Al-Kali, A, Gangat, N, Letendre, L, Hogan, W J, Litzow, M R, Patnaik, M M
Publicado em 2013

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Por Tefferi, A, Al-Kali, A, Begna, K H, Patnaik, M M, Lasho, T L, Rizo, A, Wan, Y, Hanson, C A
Publicado no Blood Cancer J (2016)

A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target

Por Yan, F, Shen, N, Pang, JX, Zhao, N, Zhang, YW, Bode, AM, Al-Kali, A, Litzow, MR, Li, B, Liu, SJ
Publicado no Leukemia (2017)

Fatty Acid Binding Protein FABP4 Mechanistically Links Obesity with Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells

Por Yan, F, Shen, N, Pang, JX, Zhang, YW, Rao, EY, Bode, AM, Al-Kali, A, Zhang, DE, Litzow, MR, Li, B, Liu, SJ
Publicado no Leukemia (2016)

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

Por Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A
Publicado no Blood Cancer J (2016)

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Por Pardanani, A, Laborde, R R, Lasho, T L, Finke, C, Begna, K, Al-Kali, A, Hogan, W J, Litzow, M R, Leontovich, A, Kowalski, M, Tefferi, A
Publicado em 2013

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

Por Haddox, C L, Mangaonkar, A A, Chen, D, Shi, M, He, R, Oliveira, J L, Litzow, M R, Al-Kali, A, Hogan, W J, Elliott, M A
Publicado no Blood Cancer J (2017)

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

Por Pardanani, A, Abdelrahman, R A, Finke, C, Lasho, T T, Begna, K H, Al-Kali, A, Hogan, W J, Litzow, M R, Hanson, C A, Ketterling, R P, Tefferi, A
Publicado no Leukemia (2015)

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

Por Saeed, L, Patnaik, M M, Begna, K H, Al-Kali, A, Litzow, M R, Hanson, C A, Ketterling, R P, Porrata, L F, Pardanani, A, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2017)